Skip to Content

Join the 'Japanese Encephalitis Virus Prophylaxis' group to help and get support from people like you.

Japanese Encephalitis Virus Prophylaxis News

Vaccine Campaign in Poor Countries to Save 20 Million Lives

Posted 10 Sep 2017 by Drugs.com

FRIDAY, Sept. 8, 2017 – In poor countries, childhood vaccines will save 20 million lives and $350 billion in health care costs by 2020, a new study says. "Vaccination is generally regarded to be one of the most cost-effective interventions in public health," said study leader Sachiko Ozawa, an associate professor at the University of North Carolina at Chapel Hill's School of Pharmacy. "Decision-makers need to appreciate the full potential economic benefits that are likely to result from the introduction and sustained use of any vaccine or vaccination program," she said in a university news release. Researchers examined the impact of Gavi, a global vaccine alliance launched in 2000 to provide vaccines to children in the world's poorest nations. Gavi has contributed to the immunization of 580 million children and has operated mainly in the 73 countries included in the analysis. The study ... Read more

Related support groups: Yellow Fever Vaccine, Gardasil, Hepatitis B Adult Vaccine, Twinrix, Pneumococcal 23-polyvalent Vaccine, Pneumovax 23, Hepatitis B Prevention, Cervarix, Rubella Virus Vaccine, Rotarix, Measles Virus Vaccine, Human Papillomavirus Vaccine, Influenza Prophylaxis, Pneumococcal Disease Prophylaxis, Measles Virus Vaccine/Mumps Virus Vaccine/Rubella Virus Vaccine/Varicella Virus Vaccine, Rotavirus Vaccine, Mumps Virus Vaccine/Rubella Virus Vaccine, Vaccination and Prophlaxis, ProQuad, Hepatitis B Prophylaxis

Vaccine Approved for Japanese Encephalitis

Posted 31 Mar 2009 by Drugs.com

TUESDAY, March 31 – The Ixiaro vaccine to prevent Japanese encephalitis (JE) has been approved by the U.S. Food and Drug Administration as the only sanctioned JE vaccine in the United States. The mosquito-transmitted virus is found mostly in Asia, where it affects up to 50,000 people each year and causes as many as 15,000 deaths, the FDA said in a news release. Though rarely seen in the United States, a few cases have been reported among people traveling to and from Asia. The JE virus affects membranes that surround the brain, often resulting in minor symptoms such as fever and headache. Severe cases commonly begin with flu-like symptoms and can progress to high fever, neck stiffness, brain damage, coma and death. The disease is not known to spread from person to person. Reported side effects from the two-dose Ixiaro vaccine may include headache, muscle pain, swelling and ... Read more

Related support groups: Japanese Encephalitis Virus Prophylaxis

Ask a Question

Further Information

Related Condition Support Groups

Vaccination and Prophlaxis

Related Drug Support Groups

Ixiaro, japanese encephalitis virus vaccine, japanese enceph vacc sa14-14-2, inactivated, Je-Vax